Leuprolide Acetate Market By Mode of Administration ( Intramuscular, Subcutaneous ), By Application ( Prostate Cancer, Uterine Fibroid ), By End-use ( Hospitals, Clinics, Medical Institutes ), Industry Trends, Estimation & Forecast, 2017 - 2025

April 2018

 Pages: 178

 ERC 9095


Leuprolide Acetate Market is expected to grow with a CAGR of xx% during the forecast period of 2018 to 2025.

Leuprolide acetate is a nonapeptide acetate salt which can be used as a substitute to the gonadotropin-releasing hormone. The leuprolide acetate hormone analogue is used for curing or inhibiting certain diseases prevalent in both men and women. Leupron is the brand name by which leuprolide acetate injections are commercialized throughout the world. The salt has been found highly efficient for certain therapies used for prohibiting the growth of prostate cancer in men. Prostate cancer is highly stimulated by the generation of testosterones in the body. Leupron acts as a LHRH agonist. LHRH is a naturally occurring hormone that stimulates the production of testosterone in the testes. The introduction of Lupron effectively blocks LHRH, and hence, it reduces the amount of testosterone in the body. Lupron has been proven highly efficient in lowering the androgen levels or stopping them from getting into prostate cancer cells. This makes prostate cancers either to shrink or to grow very slowly.

As per NIH, in 2015, there were an estimated 3,120,176 men living with prostate cancer in the United States. Lupron is also prescribed for the women dealing with endometriosis and Uterine Fibroids, which are one of the most complicated and painful diseases related to female reproductive system. As per a survey by nearly 10% of the total women worldwide are suffering with endometriosis. Such a scenario might act as a major stimulating factor for the demand of Lupron. However, generation of side effects such as redness, burning, tiredness and nausea might create a reluctance among the patients to opt this treatment. Apart from this the availability of better substitutes such as Firmagon, might act as a restraining factor for the market growth.

The report provides detailed qualitative and quantitative analysis of the Global Leuprolide Acetate Market. Market size and forecast in terms of value and volume has been provided for the period - (2017 - 2025), for the segments namely type and application in each of the major regions.

Leuprolide Acetate Market Player Analysis -

The report presents detailed analysis of major players operating in Global Leuprolide Acetate Market. Few of the include Sun Pharmaceutical Industries Ltd., Varian Pharmed , Avenit AG, Takeda Pharmaceutical Company Limited, Livzon Pharmaceutical Group Co., Ltd., Beijing Biote Pharmaceutical Co., Ltd , Soho-YImIng (China), AbbVie Inc. (U.S.), Sanofi (France), Astellas Pharma (Japan), Abbott, Merck KGaA and Pfizer Inc. A detailed coverage on these market players with information on their revenue from Leuprolide Acetate, market share, gross margin and their growth strategies have been provided in the report.

Leuprolide Acetate Market Segmentation

Global Leuprolide Acetate market is segmented on the basis of mode of administration, application, end user and geography. By mode of administration, the market is segmented into intramuscular and subcutaneous. On the basis of application, the market is categorized as prostate cancer, precocious, uterine fibroid, and others. Geographical coverage has been provided for each of the major regions including North America, Europe, Asia-Pacific, South America and Rest of the World.

Leuprolide Acetate Market Segmentation

By Mode of Administration
    • Intramuscular
    • Subcutaneous

By Application
    • Prostate Cancer
    • Uterine Fibroid
    • Others

By End-Use
    • Hospitals
    • Clinics
    • Medical Institutes
    • Others

By Geography
    • North America
              o U.S.
              o Canada
              o Mexico
    • Europe
              o U.K.
              o France
              o Germany
              o Italy
              o Spain
              o Rest of Europe
    • Asia-Pacific
              o China
              o Japan
              o India
              o Korea
              o Rest of APAC
    • South America
              o Brazil
              o Rest of South America
    • Rest of the World
              o Middle East
              o Africa

Leuprolide Acetate Market Key Players

• Sun Pharmaceutical Industries Ltd.
• Varian Pharmed
• Avenit AG
• Takeda Pharmaceutical Company Limited
• Livzon Pharmaceutical Group Co., Ltd.
• Beijing Biote Pharmaceutical Co., Ltd
• Soho-YImIng
• AbbVie Inc.
• Sanofi
• Astellas Pharma
• Abbott
• Merck KGaA
• Pfizer Inc.

Please fill in the form below to Request for Customized Report
Your personal details are safe and secured with us. Privacy Policy

To request sample copy of this report, please complete the form below verified and secure

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report. This also includes a 30 minute free analyst discussion post report purchase.

Your personal details are safe and secured with us. Privacy Policy

    What Information does this report contain?

    • What was the market size of the Leuprolide Acetate Market in 2017 and the expected market size by 2025, along with the growth rate?
    • An in-depth analysis of the current impacting factors, opportunities and challenges/restraints in the market
    • Which are the largest revenue generating products, services or regions and their comparative growth rate?
    • Which technology is in trend and how would it evolve during the forecast period (2017 - 2025)?
    • Which are the leading companies in the Leuprolide Acetate Market and their competitive positioning basis their market share, product portfolio, strategic attempts and business focus?

Purchase Options

Offers & Discounts

  • Chapter purchase
  • Historical market data
  • Country level data breakdown
  • Free customization*
  • Discounts for first time
  • Special pricing for
              non-business entities


  • We offer 20% free customization on every purchase.

Get in touch!